This is a beginner's guide to using pharmaceutical benefits scheme data. The guide outlines the overview of the PBS, what medicines are listed on the PBS, beneficiary categories and co-payments, prescription types, authority restrictions/restricted benefits, common pitfalls, tips for using PBS data, and example case studies.
This guide, developed by Anna Kemp (The University of Western Australia), Ellie Paige and Emily Banks within the Research School of Population Health at ANU, introduces researchers to the Pharmaceutical Benefits Scheme (PBS). It explains what the PBS is, which medicines are listed, beneficiary categories and co-payments, prescription types, and authority restrictions.
The document then covers common pitfalls when working with PBS data, such as below co-payment medicines, seasonality, authority changes, delisting, identity confusion and changing beneficiary status, and offers tips on defining medication use, supply periods, dose calculation and discontinuation, with example case-studies and general advice for analyses. It was last updated in August 2012.
The Pharmaceutical Benefits Scheme (PBS) is an administrative dataset initiated to monitor publicly-subsidised prescription medicines in Australia, covering anyone with a Medicare card and visitors from countries with a reciprocal health care agreement.
No. It only captures PBS-subsidised medicines dispensed in Australia, and does not include all medicines dispensed, how much of the medicine was used, or what the medicine was prescribed for.
In 2012, concessional beneficiaries paid $5.80 and general beneficiaries paid $35.60 per prescription.
Prior to April 2012, below co-payment medicines were not captured in PBS data, so dispensings to general beneficiaries are missing before that date. Since April 2012, all PBS dispensings are captured.